ACPP anticorps (Acid Phosphatase, Prostate)

Details for Product anti-ACPP Antibody No. ABIN966903, Fournisseur: Connectez-vous pour afficher
Antigène
  • 5'-NT
  • ACP-3
  • ACP3
  • PAP
  • A030005E02Rik
  • FRAP
  • Lap
  • Ppal
  • Acpp11
  • RNACPP11
  • pap
  • ACPP
  • acp-3
  • acp3
  • acpt
  • acid phosphatase, prostate
  • prostatic acid phosphatase
  • prostatic acid phosphatase, putative
  • acid phosphatase, prostate S homeolog
  • ACPP
  • Acpp
  • CpipJ_CPIJ004002
  • Smp_016640
  • acpp.S
Reactivité
Humain
250
38
17
5
5
4
4
3
3
2
2
1
1
1
Hôte
Lapin
114
102
47
8
1
1
Clonalité
Polyclonal
Conjugué
Cet anticorp ACPP est non-conjugé
17
13
13
7
7
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Application
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
112
111
90
81
72
66
54
25
12
12
4
3
2
2
2
2
2
1
1
1
Options
Fournisseur
Connectez-vous pour afficher
N° du produit (Fournisseur)
Connectez-vous pour afficher
Immunogène Human PSAP purified from seminal fluid.
Specificité This antibody reacts with PSAP specifically as demonstrated by immunoelectrophoresis and immunohistochemistry.
Purification Concentrated.
Plasmids, Primers & others Plasmids, Primers & others ACPP products on genomics-online (e.g. as negative or positive controls)
Autre désignation Prostatic Acid Phosphatase (PSAP) (ACPP Antibody Extrait)
Pathways Synaptic Membrane, Ribonucleoside Biosynthetic Process
Indications d'application Staining Procedure: This antibody can be used on frozen tissue sections and on formalin-fixed, paraffin-embedded tissue sections. Prolonged fixation in buffered formalin can destroy the epitope. The antibody may be used at a dilution of 1:50-1:100 in IHC. The optimal dilutions should be determined by the individual laboratory.
Restrictions For Research Use only
Format Liquid
Concentration 3-4mg/ml.
Buffer 20 mM tris-borate, 150 mM Sodium Chloride, BMC-6 carrier polysaccharides, carrier protein, pH 7.5
Agent conservateur Sodium azide
Précaution d'utilisation This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C
Background publications Heller: "Prostatic acid phosphatase: its current clinical status." dans: The Journal of urology, Vol. 137, Issue 6, pp. 1091-103, 1987 (PubMed).

Avez-vous cherché autre chose?